This brand name is authorized in Mexico
The drug BRISPEN contains one active pharmaceutical ingredient (API):
|
1
Dicloxacillin
UNII 4HZT2V9KX0 - DICLOXACILLIN SODIUM
|
|
Dicloxacillin is a penicillinase stable, acid-stable semisynthetic penicillin. It inhibits bacterial cell wall synthesis and has bactericidal effect on penicillin susceptible bacteria in the growth phase. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J01CF01 | Dicloxacillin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CF Beta-lactamase resistant penicillins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 64731 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
